Different in situ immune patterns between primary tumor and lymph node in non-small-cell lung cancer: potential impact on neoadjuvant immunotherapy

HIGHLIGHTS

• who: Neoadjuvant Immunotherapy and collaborators from the State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, and Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China have published the Article: Different In Situ Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy, in the Journal: Journal of Immunology Research of 28/04/2022
• what: Given that no significant difference was found between SCC and ADC regarding in situ immune pattern in this study, analyses were conducted for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.